Author:
Oliver Tim,Chung Peter W. M.,Powles Tom,Jewett Michael A. S.
Reference99 articles.
1. Anon (1985) Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours. Lancet 1(8419):8–11
2. Aparicio J, Germa JR, Garcia del Muro X, Maroto P, Arranz JA, Saenz A et al (2005) Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. [see comment]. J Clin Oncol 23(34):8717–8723
3. Barry MJ (1998) PSA screening for prostate cancer: the current controversy–a viewpoint. Patient Outcomes Research Team for Prostatic Diseases. [see comment]. Ann Oncol 9(12):1279–1282
4. van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. [see comment]. J Clin Oncol 25(28):4370–4378
5. Bhardwa JM, Powles T, Berney D, Baithun S, Nargund VH, Oliver RT (2005) Assessing the size and stage of testicular germ cell tumours: 1984-2003. BJU Int 96(6):819–821